News
A new study in The Lancet found that a deep-learning algorithm was able to detect vision-threatening retinopathy with 94.7% accuracy.
The feature is geared toward offering clinicians a holistic view of the patient.
Also, HCA Healthcare UK opens £26M specialist oncology unit at UCLH.
The pair will research how aging and the environment impact skin, and develop new digital diagnostic tools for dermatology.
Also: Truepill launches a COVID-19 test coverage platform for insurers, and 23andMe extends its partnership with GSK.
The company is looking to use the new funds to expand internationally.
Teladoc is pitching the expanded service as a way to improve primary care access.
Human Capital and Greenoaks Capital led the latest round, according to Insider’s reporting.
This comes ahead of the company's reported IPO filing by October.
One Medical shareholders will now own 73% of the joint company and Iora Health shareholders will have 27%.